With 6 cGMP/ FDA inspected plants in Europe and the United States for commercial production supported by two pre-GMP (ISO 9001) sites in France, our customers have access to a powerful industrial network of facilities with a high level of quality, safety and environmental compliance.

Seqens invests on an ongoing basis in its production sites to provide the pharmaceutical industry with state-of-the-art equipment combined with cutting-edge technology in organic chemistry associated with proprietary gene shuffling technology for unique biocatalytic routes.

We conduct GMP manufacturing of APIs or intermediates from kilo to multi-ton quantities. Our range of scale and seamless collaboration within our manufacturing sites allow Seqens to accommodate most projects regardless of size and complexity.

Our services include:

  • Process and analytical validation
  • Kilo-scale, pilot scale and commercial multi-ton cGMP manufacturing
  • Production in two locations for supply chain security
  • Quality control and quality assurance
  • Back integration of early intermediates for  supply chain security, cost or quality control
  • Special technologies like cryogenic, hydrogenation, biocatalysis
  • HPAPI containment down to 100 ng/m3 OEL ( kilo scale to 200 kg batch size )
  • Process optimization and second generation process for cost control
  • Regulatory support and filings